Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma
- Author
- SIEGHART, Wolfgang1 ; PINTER, Matthias1 ; DAUSER, Bernhard2 ; ROHR-UDILOVA, Natalya1 ; PIGUET, Anne-Christine4 5 ; PRAGER, Gerald3 ; HAYDEN, Hubert1 ; DIENES, Hans-Peter6 ; DUFOUR, Jean-Francois4 5 ; PECK-RADOSAVLJEVIC, Markus1
[1] Department of Internal Medicine III, Division of Gastroenterology/Hepatology and Comprehensive Cancer Center, Medical University Vienna, Austria
[2] KH der Barmherzigen Briider Wien, Department of Surgery, Vienna, Austria
[3] Department of Internal Medicine I and Comprehensive Cancer Center, Medical University Vienna, Austria
[4] Hepatology, Department of Clinical Research, University of Berne, Switzerland
[5] Clinic of Visceral Surgery and Medicine, Inselspital, Switzerland
[6] Department of Pathology, Medical University Vienna, Austria - Source
Journal of hepatology. 2012, Vol 57, Num 3, pp 592-599, 8 p ; ref : 32 ref
- CODEN
- JOHEEC
- ISSN
- 0168-8278
- Scientific domain
- Gastroenterology
- Publisher
- Elsevier, Kidlington
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Erlotinib Hepatocellular carcinoma Sorafenib
- Keyword (fr)
- Animal Antiangiogénique Anticancéreux Association médicamenteuse Carcinome hépatocellulaire Chimiothérapie Erlotinib Gastroentérologie Modèle Pathologie expérimentale Rat Sorafénib Anti-EGFR Cancer Dérivé de la quinazoline Enzyme Inhibiteur de la tyrosine kinase Inhibiteur enzyme Inhibiteur multikinase Mammalia Pathologie de l'appareil digestif Pathologie du foie Protein-tyrosine kinase Rodentia Traitement Transferases Tumeur maligne Vertebrata
- Keyword (en)
- Animal Antiangiogenic agent Antineoplastic agent Drug combination Hepatocellular carcinoma Chemotherapy Erlotinib Gastroenterology Models Experimental disease Rat Sorafenib Cancer Quinazoline derivatives Enzyme Tyrosine kinase inhibitor Enzyme inhibitor Multikinase inhibitor Mammalia Digestive diseases Hepatic disease Protein-tyrosine kinase Rodentia Treatment Transferases Malignant tumor Vertebrata
- Keyword (es)
- Animal Antiangiogenico Anticanceroso Asociación medicamentosa Carcinoma hepatocelular Quimioterapia Erlotinib Gastroenterología Modelo Patología experimental Rata Sorafenib Cáncer Enzima Inhibidor tyrosine kinase Inhibidor enzima inhibidor multicinasa Mammalia Aparato digestivo patología Hígado patología Protein-tyrosine kinase Rodentia Tratamiento Transferases Tumor maligno Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13C Liver. Biliary tract. Portal circulation. Exocrine pancreas / 002B13C01 Tumors
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26255962
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.jhep.2012.04.034 
https://dx.doi.org/10.1016/j.jhep.2012.04.034
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jhep.2012.04.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Journal of hepatology\";s:9:\"\u0000*\u0000stitle\";s:10:\"J. hepatol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"592\";s:8:\"\u0000*\u0000epage\";s:3:\"599\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0168-8278\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SIEGHART\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfgang\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PINTER, Matthias\";i:1;s:16:\"DAUSER, Bernhard\";i:2;s:21:\"ROHR-UDILOVA, Natalya\";i:3;s:22:\"PIGUET, Anne-Christine\";i:4;s:14:\"PRAGER, Gerald\";i:5;s:14:\"HAYDEN, Hubert\";i:6;s:18:\"DIENES, Hans-Peter\";i:7;s:21:\"DUFOUR, Jean-Francois\";i:8;s:26:\"PECK-RADOSAVLJEVIC, Markus\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOHEEC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jhep.2012.04.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Journal of hepatology\";s:9:\"\u0000*\u0000stitle\";s:10:\"J. hepatol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"592\";s:8:\"\u0000*\u0000epage\";s:3:\"599\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0168-8278\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SIEGHART\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfgang\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PINTER, Matthias\";i:1;s:16:\"DAUSER, Bernhard\";i:2;s:21:\"ROHR-UDILOVA, Natalya\";i:3;s:22:\"PIGUET, Anne-Christine\";i:4;s:14:\"PRAGER, Gerald\";i:5;s:14:\"HAYDEN, Hubert\";i:6;s:18:\"DIENES, Hans-Peter\";i:7;s:21:\"DUFOUR, Jean-Francois\";i:8;s:26:\"PECK-RADOSAVLJEVIC, Markus\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOHEEC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jhep.2012.04.034\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jhep.2012.04.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Journal of hepatology\";s:9:\"\u0000*\u0000stitle\";s:10:\"J. hepatol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"592\";s:8:\"\u0000*\u0000epage\";s:3:\"599\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0168-8278\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SIEGHART\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfgang\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PINTER, Matthias\";i:1;s:16:\"DAUSER, Bernhard\";i:2;s:21:\"ROHR-UDILOVA, Natalya\";i:3;s:22:\"PIGUET, Anne-Christine\";i:4;s:14:\"PRAGER, Gerald\";i:5;s:14:\"HAYDEN, Hubert\";i:6;s:18:\"DIENES, Hans-Peter\";i:7;s:21:\"DUFOUR, Jean-Francois\";i:8;s:26:\"PECK-RADOSAVLJEVIC, Markus\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOHEEC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jhep.2012.04.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Journal of hepatology\";s:9:\"\u0000*\u0000stitle\";s:10:\"J. hepatol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"592\";s:8:\"\u0000*\u0000epage\";s:3:\"599\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0168-8278\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SIEGHART\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfgang\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PINTER, Matthias\";i:1;s:16:\"DAUSER, Bernhard\";i:2;s:21:\"ROHR-UDILOVA, Natalya\";i:3;s:22:\"PIGUET, Anne-Christine\";i:4;s:14:\"PRAGER, Gerald\";i:5;s:14:\"HAYDEN, Hubert\";i:6;s:18:\"DIENES, Hans-Peter\";i:7;s:21:\"DUFOUR, Jean-Francois\";i:8;s:26:\"PECK-RADOSAVLJEVIC, Markus\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOHEEC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:26:\"10.1016\/j.jhep.2012.04.034\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:9:\"\u0000*\u0000jtitle\";s:21:\"Journal of hepatology\";s:9:\"\u0000*\u0000stitle\";s:10:\"J. hepatol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"57\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"592\";s:8:\"\u0000*\u0000epage\";s:3:\"599\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0168-8278\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"SIEGHART\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Wolfgang\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:16:\"PINTER, Matthias\";i:1;s:16:\"DAUSER, Bernhard\";i:2;s:21:\"ROHR-UDILOVA, Natalya\";i:3;s:22:\"PIGUET, Anne-Christine\";i:4;s:14:\"PRAGER, Gerald\";i:5;s:14:\"HAYDEN, Hubert\";i:6;s:18:\"DIENES, Hans-Peter\";i:7;s:21:\"DUFOUR, Jean-Francois\";i:8;s:26:\"PECK-RADOSAVLJEVIC, Markus\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JOHEEC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:78:\"Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma\";s:8:\"\u0000*\u0000place\";s:10:\"Kidlington\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
